• Methicillin Sodium Salt in Translational Research

  2026-08-10

  Methicillin sodium salt is more than a legacy antibiotic reference: it is a mechanistically interpretable tool for modeling MSSA, benchmarking resistance, and connecting whole-cell phenotypes with target-level evidence. This article outlines how translational researchers can use its PBP-centered biology to build more rigorous gram-positive infection studies and antibiotic discovery workflows.

• Spermine, Ion Channels, and Nuclear Egress

  2026-08-09

  Spermine is an endogenous polyamine that offers a precise way to study ion channel regulation while improving the interpretation of nuclear-envelope assays. This article distinguishes established channel pharmacology from emerging CLCC1 membrane-fusion biology and proposes a disciplined framework for cross-domain experiments.

• Doxycycline Workflows for Hydrogel Research

  2026-08-08

  Doxycycline supports more than antimicrobial experiments: it can serve as a mechanistically useful metalloproteinase inhibition arm in 3D matrix, stem-cell, and cancer research. This workflow translates rapid cell tumbling and nuclear mechanotransduction findings into controlled assays with practical formulation, imaging, and troubleshooting guidance.

• Glabridin–Gold(I) Complex Reprograms Tumor Immunity

  2026-08-07

  The reference study develops complex 6d, an N-heterocyclic carbene gold(I)–glabridin agent designed to address both tumor immunogenicity and immune suppression. Its TrxR- and MAPK-oriented strategy enhances dendritic-cell maturation, reduces suppressive immune populations, lowers PD-L1 expression, and promotes granzyme B production, providing a mechanistic basis for combination immunotherapy research.

• Redefining Co-IP: Strategic Insights for Translational Disco

  2026-08-07

  This thought-leadership article bridges mechanistic advances in protein complex isolation with actionable strategy for translational researchers, spotlighting the Protein A/G Magnetic Co-IP/IP Kit from APExBIO. By leveraging recent findings on the BATF2-ATF3 axis in intervertebral disc degeneration, and critically analyzing competitive workflow innovations, we provide a roadmap for high-fidelity protein-protein interaction analysis that transcends standard product overviews.

• Podophyllotoxin: Advanced Workflows in Cell Cycle and MDR Re

  2026-08-06

  Podophyllotoxin empowers researchers to dissect cell cycle arrest and overcome multidrug resistance in cancer models, with robust protocols for reproducibility. New evidence highlights dual-targeting derivatives and optimized workflows for autophagy and apoptosis assays.

• BGJ398 (NVP-BGJ398): Selective FGFR1/2/3 Inhibitor for Oncol

  2026-08-06

  BGJ398 (NVP-BGJ398) is a potent, selective inhibitor of FGFR1, FGFR2, and FGFR3, widely used in FGFR-driven malignancies research. Its specificity and nanomolar potency enable precise interrogation of FGFR signaling pathways and apoptosis induction in cancer cells.

• Amphotericin B: Advanced Workflows for Fungal Infection Rese

  2026-08-05

  Amphotericin B remains the gold standard polyene antifungal antibiotic for dissecting membrane sterol interactions and immune signaling in fungal infection research. This guide translates the latest synergy findings and workflow innovations into actionable protocols, troubleshooting, and optimization strategies.

• Uridine, Trisodium Salt: Benchmarking a Nucleoside Analog fo

  2026-08-05

  Uridine, Trisodium Salt is a high-purity nucleoside analog essential for RNA biosynthesis research and vascular biology. Its defined mechanism and validated solubility make it a preferred standard for workflows requiring precise RNA precursor control. Rigorous evidence supports its role in RNA-mediated transgene insertion and contractile response assays.

• Bufalin as a Cardiotonic Steroid: Optimizing Oncology Resear

  2026-08-04

  Bufalin’s dual action as a cardiotonic steroid and precise apoptosis inducer is transforming triple-negative breast cancer and hepatocellular carcinoma research. This guide details protocol parameters, troubleshooting, and workflow insights grounded in the latest peer-reviewed evidence and APExBIO’s high-purity supply.

• Fenofibrate Induces Age-Independent Liver Enlargement via PP

  2026-08-04

  This study demonstrates that fenofibrate induces liver enlargement in both adult and aging mice by activating the PPARα-YAP signaling pathway. The findings clarify that age does not diminish the hepatic response to fenofibrate, providing mechanistic insight for metabolic and aging research.

• X-ray Triggered Nano-Micelle Chemoradiation: Targeted Tumor

  2026-08-03

  Yao et al. introduce a nano-micelle platform that releases caged doxorubicin in response to X-ray-induced Cherenkov light, enabling precise nuclear delivery of chemotherapy during radiotherapy. This approach demonstrates potent tumor eradication with minimal off-target toxicity, representing a significant advance in chemoradiation selectivity and efficacy.

• Translating Epigenetic Insight: GSK126 EZH2 Inhibitor in Onc

  2026-08-03

  This thought-leadership article explores the evolving role of GSK126—a potent, selective EZH2 inhibitor—in translational cancer epigenetics research. Blending mechanistic precision with practical experimental guidance, it highlights GSK126’s impact on lymphoma, small cell lung cancer, and emerging domains such as fragile X syndrome, referencing recent breakthroughs. The piece contextualizes GSK126 within the competitive landscape, underscores its strategic value for oncology drug development, and concludes with a visionary outlook on future discovery.

• Psoralen-Induced Cholestasis: ERK1/2 Activation as a Therape

  2026-08-02

  This article reviews the mechanistic study demonstrating that psoralen and isopsoralen, phytoestrogens from Psoraleae Fructus, induce estrogenic cholestasis via ERK1/2 pathway activation in zebrafish. The findings highlight ERK1/2 as a critical node linking estrogen-like hepatotoxicity and bile acid dysregulation, with implications for targeted intervention using ERK1/2 inhibitors.

• Adipose-Neural Axis in Epicardial Fat-Linked Arrhythmias: NP

  2026-08-01

  Fan et al. (2024) established a stem cell-based coculture model to elucidate how the adipose-neural axis promotes cardiac arrhythmia through leptin-induced activation of the NPY/Y1 receptor pathway. Their work highlights new molecular intervention points for arrhythmia treatment and underscores the translational importance of dissecting neuro-adipose signaling.

445 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page